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Introduction 
 
Background and current context of the evaluation project 
 
People with a diagnosis of a long-term condition (LTC) such as diabetes, coronary heart disease (CHD), 
asthma and chronic obstructive pulmonary disease (COPD), or who have medically unexplained symptoms 
(MUS) are more frequent users of the health care system than those without these health problems.  
People with long-term conditions often have associated psychological and mental health problems such as 
anxiety and depression. People with diabetes are twice as likely to suffer mental health problems, and 
those with COPD are three times more likely; people with two or more LTC’s are seven times more likely to 
have depression. Qualitative studies have demonstrated that overwhelming anxiety at times of crisis, worry 
about the illness, and impaired coping lead to use of health care services. The outcome of medical illnesses 
is adversely affected by psychological morbidity. A number of studies have also shown that depression is 
associated with increased health care utilisation, medical costs, disability and frequent use of the accident 
and emergency department (Lusignan S et al., 2012).   
 
A number of recent health policy initiatives aim to provide the same or better services through optimal use 
of resources. One of these initiatives is the expansion of the IAPT programme to extend the benefits of 
improved access to psychological therapies to a wider range of people including those with long term 
conditions and/or medically unexplained symptoms.  
 
In December 2011 an invitation was extended to IAPT and non-IAPT services providing psychological 
therapies to apply to become an IAPT LTC/MUS Pathfinder Site. Fifteen therapy teams were selected to 
become IAPT LTC/MUS Pathfinders in February 2012, and the roll out of the project started on 1 April 2012.  
The overall aim of the IAPT LTC/MUS Pathfinder Project is to improve access to psychological therapies for 
people with long term conditions and medically unexplained symptoms. The Pathfinder teams were tasked 
with: 
 
• Identifying a potential optimal stepped care pathway for people with LTC/MUS. 
• Identifying the core therapy competencies, experience and training required to deliver talking therapies 
to people presenting with LTC/MUS and anxiety or depression. 
• Identifying potential improvement in economic factors and health utilisation across primary and 
secondary care. 
• Identifying potential clinical effectiveness and improvement in condition and status, by providing 
talking therapies to people presenting with LTC/MUS. 
 
Overview of the evaluation project 
 
The Department of Health (DH) funded IAPT LTC/MUS programme is in Phase 1, which involves the 
evaluation of the Pathfinder sites and subsequent dissemination of learning and recommendations to 
improve access to psychological therapies for people with LTC and/or MUS. Currently the DH is considering 
future funding for Phase 2 of the programme. 
 
In October 2012 the University of Surrey Evaluation Team was selected to conduct the evaluation.  The 
Evaluation Team presented its plan of evaluation of the IAPT LTC/MUS Pathfinders Project to the 
Pathfinders on the 31
st
 October 2012. The presentation was followed by discussions with Pathfinders in 3 
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breakout groups. The evaluation plan was later circulated to all Pathfinders and invited comments on how 
the evaluation could be further improved. The key messages from some of the Pathfinders included:   
 
• There had been delays in getting the pilot project up and running with most projects starting between 
August and October 2012. A consequence of this is that there are some concerns that data will be very 
limited in April 2013 when it is expected to be submitted for evaluation.   
• There should be greater emphasis on how the workforce and competence issues will be evaluated. 
• There is scepticism about the accuracy in the self-reporting of the Client Service Receipt inventory 
(CSRI), which principally relies on the memory of the clients to recall the use of health and social care 
services.   
• Generic measures, such as the Personal Health Questionnaire (PHQ-9), may not be appropriate for 
specialist services (for example, services for clients with chronic fatigue symptom). 
 
Revised evaluation plan 
 
The evaluation plan was revised in the light of the comments from Pathfinders and discussions with the 
Department of Health’s IAPT LTC/MUS Project Team. The revised evaluation is deliverable orientated 
(Appendix 1) and consists of the following key components:  
 
(1) Qualitative – information will be collected via site visits, available paper and electronic documents, and 
face-to-face discussions:  
a. Overview of service – commissioning brief, size, activity, and target client groups, etc. 
b. Care pathway analysis of the service in each Pathfinder – We will explore the types of cases for 
which they accept referrals, any demographic restrictions, and we will analyse their description 
of the type of service provided.  
c. Workforce analysis – workforce information, competence and training provisions, including job 
descriptions and job specifications. We will explore the extent to which we can differentiate 
high and low intensity workforce, and any correlation with the type of service offered. 
 
(2) Quantitative   
a. The analysis will be based on four different sources of data; 
i. The IAPT Minimum Data Set (MDS), which is currently being submitted by all IAPT pilot 
sites to the NHS Information Centre for Health and Social Care (IC).    
ii. Admitted patient, Outpatient and A&E attendance data from Hospital Episode 
Statistics. This is a major improvement in study reliability compared with reliance on 
CSRI.  The evaluation team would have left visits until after the IC data linkage had 
taken place, but the DH was keen on this starting ahead of it being available. 
iii. Additional fields for the collected data mandated by the IAPT LTC/MUS pilot like EQ-5D, 
PHQ-9 and W&SAS that are not part of the IAPT MDS. This template is given as 
Appendix 3. 
iv. Whilst not mandated for the pilot, some sites are able to identify whether a LTC or 
MUS was the reason for the referral. This template is given as Appendix 4. 
b. Pathfinders will submit data to the IC, which will link it and then anonymise it before passing it 
to the University of Surrey. The anonymised data will be imported into the Surrey Evaluation 
Team’s database server for cleaning and creation of tables for analysis. 
c. Quantitative analysis – comparing size of service, rates of referral, equity in referral to IAPT and 
their clinical outcomes, contrasting people with and without MUS and LTCs.  Including change 
in PHQ9 and other scales. 
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d. Economic analysis – to ascertain the cost-effectiveness of the service in improving outcomes of 
the different patient sub-groups (i.e. with and without MUS and/or LTCs). Our economic 
analysis will be based on mapping the change in the Work and Social Adjustment Scale 
(W&SAS), or other repeated outcomes scores, onto the EQ-5D using the methodology outlined 
in Brazier et al (2009). The mapping approach is adopted in order to follow the National 
Institute for Clinical Excellence (NICE) guidelines on incorporating health economics in 
guidelines and assessing resource impact (NICE, 2007). 
 
(3) Patient Experience Survey 
The evaluation aims to survey all of those referred to the IAPT LTC/MUS pilot services between March 
and June 2013, irrespective of whether the clients accepted therapy or not.  The survey questionnaire 
will be based on the National IAPT Patient Experience Questionnaire. 
 
Aims of the interim report 
 
At the time of this report, the Surrey Evaluation Team has completed three pilot visits to the Pathfinders 
but not received any IAPT data from the Pathfinders for analysis. However, members of the Surrey 
Evaluation Team have gained some insight into the implementation of the IAPT LTC/MUS pilot projects 
through discussions with Pathfinders in three IAPT LTC/MUS learning events, discussions with the DH IAPT 
LTC/MUS Project Team in formal meetings and teleconferences, and access to some of the documents 
shared with us by the DH IAPT Team. We have observed the system of data recording and quality at 
Southwark (South London and Maudsley NHS Foundation Trust).   
 
The interim report aims to summarise progresses on the evaluation project to-date, and comment on 
observations on the implementation of the pilot projects to-date based on formal and informal information 
received by the Surrey Evaluation Team. 
 
Sources of information for the interim report 
In the absence of routinely collected clinical data from the Pathfinders and qualitative data from site visits 
at the time of this report, information for the interim report stemmed from multiple sources: - 
 
From the DH IAPT Team –    
• Copies of successful applications for Pathfinder status (full application and abstracts) – this gives 
good contextual information on what the Pathfinders set out to achieve, and is a useful yardstick 
against which achievements could be measured.   
 
The Pathfinders have a wide range of innovative projects supported by the IAPT LTC/MUS initiative.  
For example, some Pathfinders aim to develop a model of specialist services, some aim to develop 
generalizable evidence-based guided self-help manuals for LTCs/MUS, which could be replicated in 
other areas, and others aim to develop and test training packages for qualified psychological 
wellbeing practitioners (PWPs) to enhance their skills to support people with specific LTC/MUS. 
 
• Project administrative/management records – this gives an useful overview on issues such as 
information systems in use in the collection of minimum data in the Pathfinder project teams, 
details of data requirements specified by the DH, current level of compliance with data collection 
requirements, as well as some key communications between the DH and the Pathfinders in the 
implementation of the pilot projects.   
 
From the Pathfinders –   
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Formal and informal contacts with the Pathfinders have shown that many are evaluating their projects. It is 
also evident that in some pilot projects, useful evidence-based materials for training and interventions have 
been developed. Sources of Pathfinders’ information for this interim report include:  
 
• Presentations of their work and analysis at learning events  
• Self-reported data/information 
• Informal discussions and e-mail correspondence 
 
Implementation of pilot projects to-date 
 
Summary of progress to-date of the evaluation project 
 
The Surrey Evaluation Team was established at the end of October 2012 after a successful tender. Since 
October 2012, the Surrey Evaluation Team has established internal arrangements, which are our norm for 
managing evaluative and research projects. We take an agile approach to evaluation being flexible to meet 
the needs and challenges of the task. This flexibility has been key in enabling us to explore and obtain more 
reliable data than CSRI would have delivered and to make greater use of other outcome variables.   
 
Working with the DH IAPT Team and the Pathfinders, the Surrey Evaluation Team has made good 
progresses in the evaluation project:   
 
1. Evaluation plan: The Surrey Evaluation Team presented our proposed evaluation plan to the 
Pathfinders and invited comments from the funder of this project and Pathfinders. The evaluation plan, 
with an emphasis on more accurate and reliable data (IC link), broader outcome measures if available, 
and relevant deliverables, has been revised in the light of the consultation. 
 
2. IAPT LTC/MUS learning events: The Surrey Evaluation Team participated in a number of Pathfinder 
learning events. The key objective was to gain some insight into contextual information and details of 
some of the Pathfinder projects and to meet some of the project leads of the Pathfinder pilots. 
 
3. Site visits: The Surrey Evaluation Team met with project leads of the IAPT LTC/MUS Pathfinder Project 
for Southwark and Bexley in January in a formal visit, to pilot the potential scope of such visits.  The 
visit also piloted an information gathering schedule for the implementation of site visits as part of the 
evaluation plan. A systematic series of Pathfinder site visits by the Evaluation Team began on 21
st
 
February 2013, when the Berkshire MUS scheme and Berkshire West Diabetes project were visited. 
Visits to other Pathfinders are being arranged for March and April of this year. 
 
4. Data collection for quantitative analysis: The Surrey Evaluation Team participated in a teleconference 
and subsequent meetings with the DH IAPT Team and the NHS Information Centre (IC).   
 
The key outcomes of these discussions included: 
• The Surrey Evaluation Team has devised a data template that appears acceptable for data provision 
and aggregation.   
• The DH IAPT Team will invite the Pathfinders to send the local patient identifiable IAPT LTC/MUS 
data files directly to the IC. 
• The Information Centre will link and de-identify the IAPT Minimum dataset; HES and other relevant 
local data held by Pathfinders and make them available to the Surrey Evaluation team. 
• As alluded to above, new legislation (Health and Social Care Act) in place covering care records 
means that there is now a clearer legal framework for data sharing. NHS IC will have new powers in 
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April 2013 to access patient identifiable data, which could mean that data sharing agreements with 
individual Pathfinders will not be necessary (to be confirmed by the DH IAPT Team). 
 
5. Patient Experience Survey: The survey questionnaire (Appendix 2) is currently in a draft form. It is an 
adapted version of the National IAPT Patient Experience Questionnaire, and includes the additional 
standard NHS ‘friend and family test’ question.   
 
The Surrey Evaluation Team is currently consulting Pathfinders on the proposed questionnaire and 
survey method. It is planned that all comments from Pathfinders should reach the Surrey Evaluation 
Team by the end of February with a view to conducting the survey of all new referrals to the pilot 
services between March and June 2013.  
 
Findings and observations to-date 
 
We have not yet received the routinely collected clinical data for analysis, or access to the documented 
outputs for all of the Pathfinders; the interim report is very likely an understatement of the breadth and 
depth of the success of the IAPT LTC/MUS Pathfinder Initiative.  However, working with the DH IAPT Team 
and the Pathfinders in the last few months has shown that, with no exceptions, the practitioners and 
managers of the Pathfinder projects are well motivated and enthusiastic about their pilot projects that aim 
to make a contribution to improving the psychological wellbeing for people with LTC and MUS.  We have 
the following observations: 
 
Pathfinder projects  
 
Initial observations from site visits reflect views expressed at the Pathfinder meetings, and highlight 
creativity and diversity in the organisation, and delivery of talking therapies for people with psychological 
comorbidity in long-term conditions and/or medically unexplained symptoms. Therapists try to avoid 
psychological terminology as a perception that symptoms are not real but in the mind might deter patients. 
Indeed, precise classification is seen as problematic due to the blurred boundaries of affective symptoms in 
LTC and MUS; patients with LTC may have MUS, and vice versa.  A causal relationship between physical and 
mental conditions is rarely straightforward, but symptoms are often interactive. This requires a holistic 
approach, which is arguably a major step forward from the compartmentalising tendency of orthodox 
medicine and healthcare.  Good partnership work with primary and secondary care is seen as vital.  
 
Data collection is a topic of much interest to Pathfinder staff. While the need for good evaluation data is 
acknowledged, the CSRI continues to draw criticism and it appears that much of the data from this 
instrument is likely to be incomplete and inaccurate; many patients are unable to recall service use reliably. 
Use of routinely collected primary and secondary care data is recommended. Concern is expressed about 
the burdensome questionnaires, which take around half an hour to complete and in some cases could 
detract from the therapeutic benefit derived from the therapy session.   
 
As well as anecdotal evidence of the effectiveness of Pathfinder schemes, the Berkshire West Diabetes 
project is running as a randomised trial (diabetes-specific therapy groups compared to standard CBT 
groups, both run by PWPs), producing statistically significant evidence in support of the experimental 
intervention.   
 
Recommendations are made for workforce competence and training. Pathfinders have devised their own 
training material for therapists and for primary and secondary care clinicians. While therapists are already 
trained in generic CBT, Pathfinder opinion is that specialised training and supervision are crucial for LTC and 
MUS. While some good results may be achieved with PWPs at low intensity, a comprehensive stepped-care 
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model is recommended, as many patients have highly complex needs requiring high-intensity, individual 
input.  
 
Uncertainty about future funding, and consequent difficulties in planning, is a major issue for Pathfinders. 
This lack of continuity occurred just as referrals from primary and secondary care had gained momentum, 
and also restricts longer-term evaluation of patients. Not surprisingly, the Pathfinder managers and staff 
are keen to develop their schemes should phase two be approved.  
 
The breadth of the service models is documented in the Pathfinders abstract (Appendix 3).  The 
overwhelming observation is that the Pathfinder initiative gives practitioners and managers of local services 
the space and time to apply research evidence systematically in clinical practice, in order to improve the 
care, including psychological care for people with LTC/MUS, often across primary and secondary healthcare 
organisational boundaries. Some projects border onto research by seeking generalizable knowledge as an 
explicit goal.  The common theme to all the Pathfinders is that they seek to deliver effective interventions 
through: -  
 
• Application of research evidence in clinical practice – Examples of such applications are much in 
evidence.  For example, the Bexley and Southwark IAPT Pathfinders developed a stepped/matched care 
pathway and pioneered a mindfulness-based cognitive therapy/stress reduction groups for people with 
pain and persistent physical problems. In Northamptonshire, the project focuses on the use of 
teleconference group work with people with COPD (Chronic Obstructive Pulmonary Disease) and 
common mental health problems. 
 
• Development of a training programme and addressing of workforce and competence issues in the 
delivery of evidence-based practice – we observed that training and competence development is a 
consistent feature in all Pathfinder projects.  For example, the London Cluster developed an evidence-
based training programme with input from local specialists to improve the skills of all IAPT staff in 
working with people with LTC/MUS; and in Hull, the project aims to develop materials to enhance 
PWPs’ skills in engaging patients with MUS.  
 
• Development of local clinical networks and care pathways – there are no Pathfinder projects which do 
not involve collaborative arrangements.  For example, the London Cluster developed local stepped-care 
pathways to ensure the integration of IAPT into key LTC pathways, and the Haringey and Barnet 
Pathfinder developed assertive outreach psychological therapy model taking the IAPT stepped care into 
the physical care centre. 
 
Quantitative data issues 
 
The majority of the Pathfinders, but not all, use either PC-MIS or IAPTus information system to record the 
IAPT Minimum Data Set (MDS). The PC-MIS and the IAPTus are separate from the Pathfinders’ main 
clinical/management information systems that provide routine data for NHS central returns.  Five 
Pathfinders do not seem to have documented which system, if any, are being used in the collection of the 
IAPT MDS, which of course does not mean that these Pathfinders do not use a data recording system. 
 
Other data items to support Pathfinder project evaluation and local analysis, for example, EQ-5D, CSRI and 
other condition specific measures, are collected through local CCG (Clinical Commissioning Group) 
supported data bases and Microsoft Excel spread sheets.  These databases are separate systems from the 
PC-MIS and IAPTus.  Integrating the data is theoretically possible using the patient ID, and some Pathfinders 
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in fact integrate the data from the separate databases manually in Excel to provide a ‘full’ LTC/MUS record 
for patients referred to their services. 
 
We had the opportunity of viewing the information systems of one Pathfinder (Southwark and Bexley), 
which has an identified data lead for the project; the data quality for this Pathfinder is good.  However, 
records maintained by the DH IAPT showed that in October 2012, self-reported data compliance among the 
Pathfinders varied between 100% and 0% (with two-thirds reporting compliance of 75% or above). Data 
quality overall is unknown at the present time. It is our recommendation that if Phase 2 is funded, 
Pathfinders should provide a named data lead to ensure that data quality is addressed, and that systems 
are in place to record and extract data to support national and local evaluations. 
 
During the visit to Southwark and Bexley, we noted that the PHQ and EQ-5D scores are recorded at an 
aggregated level and not at the individual item level. For the economic evaluation, we will require to map 
the individual item scores (and not the aggregated scores) from the PHQ to the EQ-5D.  This may be a 
challenge for Pathfinders, and we will liaise with the system suppliers and we are working with the Institute 
of Psychiatry to seek possible solutions.   
 
Discussions  
 
Principal findings 
 
Our impression is that the IAPT MUS Pathfinders really feel they are working the cutting edge.  
 
“There is really no clear dividing line between LTC and MUS; most of the patients with LTC also 
have MUS and visa versa” 
 
 “This is true holistic care” 
 
The sites feel they are not just delivering CBT, they are engaging in a much more holistic care.  There 
appear to be a range of sub studies and investigations. The West Berkshire Diabetes project is running a 
randomised trial. 
 
The sites are really trying to develop true holistic mind and body medicine.  
 
Our main observation to-date is the value of this service to people with a wide range of MUS and LTCs. 
Therapists and their managers report how working with set client groups is easier, as it is possible to more 
readily understand how symptoms might be physical or psychological in conditions you become familiar 
with.   
 
The main limitations of this service from the evaluative perspective are that service delivery started late in 
the year and that no two services are the same.  The dissimilarities extend from databases (or even spread-
sheets) used to hold the minimum and extended databases, through to the type of services offered, and 
the workforce provided to deliver it. 
 
Implications of the findings 
 
The service is likely to be of value and should continue. For a Phase 1 pilot it may have been reasonable to 
allow a range of very different services; Phase 2 should ensure that services are run on a scale and scope 
that includes worthwhile local or national evaluation.  It is too early to impose a National competence and 
service framework; however this needs to be a goal for March 2014.    
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The Phase 2 collection should continue to deliver a range of models of care, of eligible client groups, and of 
data collection so that it is more likely that impact can be measured.  CSRI should be dropped for phase 2, 
with on-going IAPT-hospital data linkage.  However, a new linkage would need to be developed to 
measures consultations in primary care.    
 
Creating a collaborative working environment 
 
There are what we hope are teething issues in the conduction of the evaluation. We are looking to flag and 
resolve these as soon as possible. 
• Evaluation method & communications issues.  The tender does not specify a project management 
method. The Evaluation team have a long experience of running and participating in evaluations an 
prefer a flexible approach deploying resources to maximise effectiveness at the points in a project  
where data are available. 
o We have agreed to a detailed set of milestones. However, we have some reservations in 
conducting visits pre-quantitative data. 
o Competencies will be mapped by a project at another provider. 
o Older people have been suggested for special evaluation.  We have requested information 
from Pathfinders on the proportion of cases over 65years and 75 years.   
o Communication and use of resources.  Please can we set notice periods, meeting dates and 
volume of meetings commensurate with the needs of the project.    
 
Conclusion and recommendations 
 
This is an emerging story of success and building momentum.   
 
Phase 2 should reduce the variability in the services where no detailed evaluation or quality data are 
collected.  Data collection, workforce profile, and complete patient data are essential for evaluation.  
Considerable effort has gone into creating a range of services and more time and data needed to 
understand which models are most effective.   
 
Our recommendations are: 
• Data and database issues: 
o Phase 2 should mandate a more specific data template that local schemes must use in this 
phase.   This should also include reporting local evaluation projects.  We recommend that a 
field is added to flag if an LTC or MUS was the primary reason for referral.  This is not part 
of the current dataset.  
o This could be generated based on the data template we have developed for use in this 
evaluation. We are happy for this to be used in this way; however, we would like this 
acknowledged.    
o If a Pathfinder has a non-auditable data system (e.g. a spread-sheet), we would 
recommend that migration to a more auditable data system should be mandated for Phase 
2. 
o DH should consider dropping CSRI 
o HES-IAPT dataset linkage should become part of the routine service monitoring as an 
alternative to CSRI. 
• Service configuration issues.  There are predominantly two types of service:  (1) Condition specific 
(i.e. where a patient with either pre-defined long term conditions – such as COPD, or a set 
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symptom like chest pain, can be referred).  OR (2) Generic services where any problem can be 
referred.   
o We suggest that four specific types of service are offered in Phase 2 
o That consideration is given to setting a fixed number of conditions  
• Workforce and intervention issues.   It is clear from our immediate overview that there is no easy 
division of the workforce into low and high intensity workers and where does computerised CBT 
and other less labour intensive interventions fit in. Beginning to encourage standardisation may 
help comparisons and metrics of these services; thought this may not be possible before the end of 
Phase 2. 
 
We have been impressed by the range of services and commitment of the IAPT teams.   Moreover the local 
IAPT teams seem clear in their belief that there are benefits for patients from their services.   Phase 2 
should be funded.  There should be a modest reduction in variability between schemes without stifling 
innovation.  There needs to be an absolute commitment in phase 2 to collecting a revised dataset and 
sharing any additional local evaluation data.  
 
Appendix 
  
Appendix 1 Deliverable time-table 
Appendix 2 Patient Experience Survey Questionnaire 
Appendix 3 Data collection template from local system 
Appendix 4 Data collection specification from local spread sheet (where it exists) 
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Appendix 1 
 
Evaluation plan: deliverables: 
Deliverables/progress report Start End  
 
1. Literature review.  Initial review completed, final version 
will be available by end March.     
2. Liaison about dataset. Liaise with the Pathfinders 
Evaluation Programme Funder and the 15 Pathfinders to 
ascertain the completeness of data 
3. Stake-holder engagement.  The project team will consult 
stake-holders of the 15 Pathfinder sites on the evaluation 
and attend IAPT LTC/MUS events 
4. The project team will visit each Pathfinder sites. First pilot 
visit conducted (21/1/2013); protocol for process to be 
developed for visits 2
nd
 and 3
rd
 quarters of 2013.  Our goal 
is to complete half the visits by end July and all by end 
September 2013 
5. Implementation of a Patient Experience Survey.  We will 
outline the methodology, consult with Pathfinders and 
collate any available results.  This is carried out in parallel 
with the site visits. The first of these took place on 21/1/13. 
6. Qualitative overview of service, Care pathway analysis & 
Workforce analysis from service descriptors e.g. 
commissioning brief, size activity. This activity needs to be 
complete ahead of the arrival of the combined data from 
the Information Centre.  The extent to which high and low 
intensity members of the workforce can be differentiated 
will be ascertained at the workforce event 31/1/13 
7. Putting permissions in place for the data to be processed 
via the IC, rather than directly collected by the evaluation 
team.  We understand that 14/4/13 is the latest date the IC 
can accept data. 
8. Quantitative analysis. This takes two parts – a qualitative 
analysis of the data to describe the service and its impact.  
And an economic evaluation.  
9. Dissemination plan.   This includes regular and ad-hoc 
reports throughout the evaluation period, being available 
for DH/NHS meetings/workshops, and submission of peer 
review publications. Report will however be submitted to 
DH by the 30/9/2013.   
10. Project Steering Board   Established board 1/11/12.  First 
meeting 29/1/13 
 
 
8/1/13 
 
31/10/12 
 
31/10/12 
 
 
21/1/13 
 
 
21/1/13 
 
 
 
15/12/12 
 
 
 
 
15/1/13 
 
 
13/5/13* 
*on receipt of 
linked data 
15/1/13 
 
 
1/11/12 
 
 
31/3/13 
 
31/3/13 
 
7/1/14 
 
 
31/5/13 
 
 
31/8/13 
 
 
 
31/8/13 
 
 
 
 
14/4/13 
 
 
31/8/13 
 
7/1/14 
 
 
19/11/13 
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Appendix 3: Evaluation of IAPT for LTC and MUS : Data collection template from local system 
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Field Name Format Comments 
IAPT Data 
dictionary 
LocalID an10   Yes 
OrgCodeOfProvider an5   Yes 
NHS_Number n10 
Used by NHS IC for Linkage only - Not 
to be passed to the evaluation agency Yes 
GP Practice Code a8  Yes 
DOB DD/MM/CCYY 
Used by NHS IC for Linkage only - Not 
to be passed to the evaluation agency Yes 
Gender an1   Yes 
Postcode_of_usual_address an8 
Used by NHS IC for Linkage only - Not 
to be passed to the evaluation agency Yes 
Service request ID an20   Yes 
LTC Condition 1 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of LTC Yes 
LTC Condition 2 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of LTC Yes 
LTC Condition 3 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of LTC Yes 
LTC Condition 4 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of LTC Yes 
LTC Condition 5 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of LTC Yes 
MUS Condition 1 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of MUS Yes 
MUS Condition 2 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of MUS Yes 
MUS Condition 3 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of MUS Yes 
MUS Condition 4 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of MUS No 
MUS Condition 5 an50 
See "Long Term Conditions and 
Medically Unexplained Symptoms Data 
Collection Summary" for list of MUS No 
Initial PHQ9-Q1 an2 Detailed responses from PHQ9 Initial No 
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Initial PHQ9-Q2 an3 
Initial PHQ9-Q3 an4 
Initial PHQ9-Q4 an5 
Initial PHQ9-Q5 an6 
Initial PHQ9-Q6 an7 
Initial PHQ9-Q7 an8 
Initial PHQ9-Q8 an9 
Initial PHQ9-Q9 an10 
score.  This is needed to mapping PHQ-
9 on to EQ-5D 
 
Initial PHQ-9 Score   Initial Score for PHQ-9 Yes 
Final PHQ9-Q1 an11 
Final PHQ9-Q2 an12 
Final PHQ9-Q3 an13 
Final PHQ9-Q4 an14 
Final PHQ9-Q5 an15 
Final PHQ9-Q6 an16 
Final PHQ9-Q7 an17 
Final PHQ9-Q8 an18 
Final PHQ9-Q9 an19 
Detailed responses from PHQ9 final 
score.  This is needed to mapping PhQ-
9 on to EQ-5D No 
Final PHQ-9 Score   FinalScore for PHQ-9 Yes 
Intal W&SAS-Q1 an20 
Intal W&SAS-Q2 an21 
Intal W&SAS-Q3 an22 
Intal W&SAS-Q4 an23 
Intal W&SAS-Q5 an24 
Detailed responses from PHQ9 final 
score.  This is needed to mapping 
W&SAS to EQ-5D No 
Initial W&SAS Score     Yes 
Final W&SAS-Q1 an25 
Final W&SAS-Q2 an26 
Final W&SAS-Q3 an27 
Final W&SAS-Q4 an28 
Final W&SAS-Q5 an29 
Detailed responses from PHQ9 final 
score.  This is needed to mapping 
W&SAS to EQ-5D No 
Final W&SAS Score a2   Yes 
Initial CSRI-Q1 a1 
Initial CSRI-Q2 a1 
Initial CSRI-Q3 a1 
Initial CSRI-Q4 n3 
Initial CSRI-Q5 a1 
Initial CSRI-Q6 n2 
Initial CSRI-Q7 a1 
Initial CSRI-Q8 n2 
Initial CSRI-Q9 a1 
Initial CSRI-Q10 n2 
Initial CSRI-Q11 a1 
Initial CSRI-Q12 n2 
Initial CSRI-Q13 a1 
Detailed response to initial Client 
Service Receipt Inventory   
No 
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Initial CSRI-Q14 n2 
Initial CSRI-Q15 a1 
Initial CSRI-Q16 n2 
Initial CSRI-Q17 a1 
Initial CSRI-Q18 n2 
Initial CSRI-Q19 a1 
Initial CSRI-Q20 n2 
Initial CSRI-Q21 a1 
Initial CSRI-Q22 n2 
Initial CSRI-Q25 a1 
Initial CSRI-Q26 n2 
Initial CSRI-Q27 a1 
Initial CSRI-Q28 n2 
Initial CSRI-Q29 n2 
Initial CSRI-Q30 n2 
Iniital CSRI Date DD/MM/CCYY 
  
Final CSRI-Q1 a1 
Final CSRI-Q2 a1 
Final CSRI-Q3 a1 
Final CSRI-Q4 n3 
Final CSRI-Q5 a1 
Final CSRI-Q6 n2 
Final CSRI-Q7 a1 
Final CSRI-Q8 n2 
Final CSRI-Q9 a1 
Final CSRI-Q10 n2 
Final CSRI-Q11 a1 
Final CSRI-Q12 n2 
Final CSRI-Q13 a1 
Final CSRI-Q14 n2 
Final CSRI-Q15 a1 
Final CSRI-Q16 n2 
Final CSRI-Q17 a1 
Final CSRI-Q18 n2 
Final CSRI-Q19 a1 
Final CSRI-Q20 n2 
Final CSRI-Q21 a1 
Final CSRI-Q22 n2 
Final CSRI-Q25 a1 
Final CSRI-Q26 n2 
Final CSRI-Q27 a1 
Final CSRI-Q28 n2 
Final CSRI-Q29 n2 
Final CSRI-Q30 n2 
Detailed response to final Client Service 
Receipt Inventory   
No 
 17 
 
Iniital CSRI Date DD/MM/CCYY   
Final CGIS a1 Final Clinical Global Impression Scale    
Initial CGIS a1 Initial Clinical Global Impression Scale    
Initial EQ-5D - Q1 n1 
Initial EQ-5D - Q2 n1 
Initial EQ-5D - Q3 n1 
Initial EQ-5D - Q4 n1 
Initial EQ-5D - Q5 n1 Eq-5D version 3L Questions 
Initial EQ-5D Score n3 EQ-5D VAS Score Yes 
Final EQ-5D - Q1 n1 
Final EQ-5D - Q2 n1 
Final EQ-5D - Q3 n1 
Final EQ-5D - Q4 n1 
Final EQ-5D - Q5 n1 Eq-5D version 3L Questions 
Final EQ-5D Score n3 EQ5D VAS Score Yes 
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Appendix 4 – Data collection specification from local spread sheet (where it exists)  
 
The current IAPT data collection summary dose not have a facility to identify if a LTC or MUS was 
the primary reason for a referral.  However, at the workshop, many pilot sites advised us that they 
kept a local spreadsheet held this data. 
 
Field Name Format Comments 
IAPT 
Data 
dictionary 
LocalID an10   Yes 
OrgCodeOfProvider an5   Yes 
NHS_Number n10 
Used by NHS IC for Linkage only - Not to 
be passed to the evaluation agency Yes 
GP Practice Code a8 
Used by NHS IC for Linkage only - Not to 
be passed to the evaluation agency Yes 
DOB DD/MM/CCYY 
Used by NHS IC for Linkage only - Not to 
be passed to the evaluation agency Yes 
Gender an1   Yes 
Postcode_of_usual_address an8 
Used by NHS IC for Linkage only - Not to 
be passed to the evaluation agency Yes 
Service request ID an20   Yes 
LTC Condition 1 an50 
Free text: Suggested LTCs: Congestive 
heart failure, Dementia, Diabetes, Liver 
disease, Peptic ulcer, Peripheral vascular 
disease, Pulmonary disease, Cancer, 
Diabetes, Paraplegia, Renal disease, 
Metastatic cancer, Severe liver disease No 
LTC Condition 1 s  primary 
reason for referral  an1 (Values - Y for Yes, N for No) No 
MUS Condition 1 an50 
free text: Suggested conditions: 
Fibromyalgia, Irritable Bowel Syndrome, 
Chronic Fatigue Syndrome, 
Tempromandibular Joint (TMJ) dysfunction, 
Atypical facial pain, Atypical chest pain, 
Hyperventilation, Chronic Cough, Loin Pain 
haematuria syndrome, Functional 
Weakness / Movement Disorder, 
Dissociative (Non-epileptic) Attacks, 
Chronic pelvic pain/ Dysmenorrhoea No 
MUS Condition 1 is primary 
reason for referral  an1 (Values - Y for Yes, N for No) No 
 
